Radical Catheter Technologies Announces FDA Clearance for 6F Neurovascular Catheter

Key Takeaways

• 6F catheter receives FDA 510(k) clearance
• Enables radial and femoral access for MMA embolisation
• Patented ribbon technology offers flexibility, push, and stability
• Integrates with NTI portfolio, e.g., Serenity River stent
• Will be displayed at SNIS 2026 meeting in Seattle

Pulse Analysis

The neurovascular catheter market has been driven by demand for smaller‑profile devices that can navigate tortuous cerebral vessels while preserving procedural efficiency. Radical’s 6F catheter leverages patented ribbon technology—a thin‑wall construction that maximizes inner diameter without sacrificing outer flexibility. This engineering advantage translates into smoother delivery of adjunctive therapies, reduced vessel trauma, and the ability to perform embolisation of the middle‑meningeal artery via both radial and femoral routes, a capability that many competitors still lack.

Regulatory clearance under the FDA’s 510(k) pathway signals that the 6F catheter meets safety and performance benchmarks comparable to existing predicate devices, yet it introduces distinct mechanical benefits. For hospitals and interventionalists, the approval reduces adoption barriers, as reimbursement and institutional review processes often hinge on FDA status. Moreover, the clearance reinforces Radical’s strategic vision of building a modular platform that can host a suite of neurovascular tools, from stents to flow diverters, fostering a one‑stop solution for complex endovascular cases.

Looking ahead, Radical’s participation in the Society of Neurointerventional Science’s 2026 annual meeting provides a high‑visibility stage to attract clinicians, investors, and potential partners. By aligning its catheter platform with complementary NTI technologies—such as Serenity’s River stent for refractory intracranial hypertension—the company is poised to capture a larger share of the growing neurointervention market, which analysts project to exceed $5 billion globally within the next five years. Continued innovation and strategic collaborations will be key to sustaining this momentum.